Abstract
Background
The role of reconstruction after primary tumor surgery for metastatic breast cancer remains controversial. This report describes the outcomes for patients undergoing mastectomy with and without reconstruction in the setting of de novo stage 4 breast cancer.
Methods
Using a prospectively maintained institutional breast surgery database, this study identified all patients who presented with de novo stage 4 breast cancer from January 2008 to December 2018. Patients were included if they had undergone mastectomy with or without reconstruction. Patient, surgical characteristics, and survival outcomes were abstracted and analyzed.
Results
The study identified 29 patients: 8 patients (28%) who underwent reconstruction (R) and 21 patients (72%) who did not (NR). Complete clinical response to induction systemic therapy was more frequent among patients in the R group than among those in the NR group for the primary disease (50% in R, 5% in NR), and to a lesser degree for distant disease (63% in R, 39% in NR). No difference in complication rates between the two groups was identified [n = 1 (13%) in R; n = 2 (10%) in NR; p = 1.0]. Overall survival from surgery was longer in the R group (100% at 2 and 5 years) than in the NR group [85%; 95% confidence interval (CI), 68–100% at 2 years vs 50%; 95% CI 27–91% at 5 years] (p = 0.046).
Conclusion
Breast reconstruction after mastectomy may be reasonable to consider for appropriately selected patients with de novo stage 4 breast cancer who have excellent responses to systemic therapy and anticipated durable survival.
Similar content being viewed by others
References
Wu SG, Li H, Tang LY, et al. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: a SEER database analysis. Tumour Biol. 2017;39:1010428317705082.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA: Cancer J Clin. 2018;68:7–30.
Weiss A, Chu CK, Lin H, et al. Reconstruction in the metastatic breast cancer patient: results from the National Cancer Database. Ann Surg Oncol. 2018;25:3125–33.
Caswell-Jin JL, Plevritis SK, Tian L, et al. Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review. JNCI Cancer Spectr. 2018;2:pky062.
Thomas A, Khan SA, Chrischilles EA, Schroeder MC. Initial surgery and survival in stage IV breast cancer in the United States, 1988–2011. JAMA Surg. 2016;151:424–31.
Gnerlich J, Dueker JM, Jeffe DB, Deshpande AD, Thompson S, Margenthaler JA. Patient and tumor characteristics associated with primary tumor resection in women with stage IV breast cancer: analysis of 1988–2003 SEER data. Breast J. 2008;14:538–42.
Lu S, Wu J, Fang Y, et al. The impact of surgical excision of the primary tumor in stage IV breast cancer on survival: a meta-analysis. Oncotarget. 2017;9:11816–23.
Warschkow R, Guller U, Tarantino I, et al. Improved survival after primary tumor surgery in metastatic breast cancer: a propensity-adjusted, population-based SEER trend analysis. Ann Surg. 2016;263:1188–98.
Lane WO, Thomas SM, Blitzblau RC, et al. Surgical resection of the primary tumor in women with de novo stage IV breast cancer: contemporary practice patterns and survival analysis. Ann Surg. 2019;269:537–44.
Badwe R, Hawaldar R, Nair N, et al. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial. Lancet Oncol. 2015;16:1380–8.
Soran A, Ozmen V, Ozbas S, et al. Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation: protocol MF07-01. Ann Surg Oncol. 2018;25:3141–9.
Durrant CA, Khatib M, Macneill F, James S, Harris P. Mastectomy and reconstruction in stage IV breast cancer: a survey of UK breast and plastic surgeons. Breast Edinburgh Scotland. 2011;20:373–9.
Dauplat J, Kwiatkowski F, Rouanet P, et al. Quality of life after mastectomy with or without immediate breast reconstruction. Br J Surg. 2017;104:1197–206.
Fischer JP, Fox JP, Nelson JA, Kovach SJ, Serletti JM. A longitudinal assessment of outcomes and healthcare resource utilization after immediate breast reconstruction: comparing implant- and autologous-based breast reconstruction. Ann Surg. 2015;262:692–9.
Chen H, Zhang M, Wang M, Zhang P, Bai F, Wu K. Immediate breast reconstruction in de novo metastatic breast cancer: an analysis of 563 cases based on the SEER database. Clin Breast Cancer. 2019;19:e135–41.
Amin MB, Edge SB, Greene FL, et al (eds). AJCC (American Joint Committee on Cancer). Cancer Staging Manual. 8th ed. 3rd printing. Springer, Chicago, 2018.
Wolff AC, Hammond MEH, Allison KH, et al. Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline-Focused Update. J Clin Oncol. 2018;36:2105–22.
Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. JNCI J Natl Cancer Instit. 2000;92:205–16.
Behnam AB, Nguyen D, Moran SL, Serletti JM. TRAM flap breast reconstruction for patients with advanced breast disease. Ann Plast Surg. 2003;50:567–71.
Aliu O, Zhong L, Chetta MD, et al. Comparing health care resource use between implant and autologous reconstruction of the irradiated breast: a national claims-based assessment. Plast Reconstr Surg. 2017;139:1224e–31e.
Neuman HB, Morrogh M, Gonen M, Van Zee KJ, Morrow M, King TA. Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter? Cancer. 2010;116:1226–33.
Olson EM, Najita JS, Sohl J, et al. Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era. Breast Edinburgh Scotland. 2013;22:525–31.
Bafford AC, Burstein HJ, Barkley CR, et al. Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival. Breast Cancer Res Treat. 2009;115:7–12.
Blanchard DK, Shetty PB, Hilsenbeck SG, Elledge RM. Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg. 2008;247:732–8.
Nano MT, Gill PG, Kollias J, Bochner MA, Malycha P, Winefield HR. Psychological impact and cosmetic outcome of surgical breast cancer strategies. ANZ J Surg. 2005;75:940–7.
Elswick SM, Harless CA, Bishop SN, et al. Prepectoral implant-based breast reconstruction with postmastectomy radiation therapy. Plast Reconstr Surg. 2018;142:1–12.
Ho AY, Hu ZI, Mehrara BJ, Wilkins EG. Radiotherapy in the setting of breast reconstruction: types, techniques, and timing. Lancet Oncol. 2017;18:e742–53.
Shammas RL, Ren Y, Thomas SM, Hollenbeck ST, Greenup RA, Blitzblau RC. Immediate breast reconstruction allows for the timely initiation of post-mastectomy radiation therapy. Plast Reconstr Surg. 2019;144:347e–57e.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Asaad, M., Meaike, J., Yonkus, J. et al. Breast Reconstruction in the Setting of Stage 4 Breast Cancer: Is It Worthwhile?. Ann Surg Oncol 27, 4730–4739 (2020). https://doi.org/10.1245/s10434-020-08879-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-08879-8